[2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate

C94H64ClN15O12S5 — CID 158479488

IUPAC[2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate
SMILESCOc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.Cc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.Cc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.O=COc1csc(-n2nc(-c3ccc(Cl)cc3)c3ccccc32)n1.O=COc1csc(-n2nc(-c3ccc(Oc4ccccc4)cc3)c3ccccc32)n1
InChIInChI=1S/C23H15N3O3S.C18H13N3O3S.2C18H13N3O2S.C17H10ClN3O2S/c27-15-28-21-14-30-23(24-21)26-20-9-5-4-8-19(20)22(25-26)16-10-12-18(13-11-16)29-17-6-2-1-3-7-17;1-23-13-8-6-12(7-9-13)17-14-4-2-3-5-15(14)21(20-17)18-19-16(10-25-18)24-11-22;2*1-12-6-8-13(9-7-12)17-14-4-2-3-5-15(14)21(20-17)18-19-16(10-24-18)23-11-22;18-12-7-5-11(6-8-12)16-13-3-1-2-4-14(13)21(20-16)17-19-15(9-24-17)23-10-22/h1-15H;2-11H,1H3;2*2-11H,1H3;1-10H
InChIKeyHHIQBWGWATXDKU-UHFFFAOYSA-N
MW1791.43 g/mol
LogP21.49
Rot. Bonds23

About [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate

[2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate (PubChem CID 158479488) has the molecular formula C94H64ClN15O12S5 and a molecular weight of 1791.43 g/mol. Its IUPAC name is [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate.

Molecular Properties

Compound Name[2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate
PubChem CID158479488
Molecular FormulaC94H64ClN15O12S5
Molecular Weight1791.43 g/mol
Exact Mass1789.32
IUPAC Name[2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate
SMILESCOc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.Cc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.Cc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.O=COc1csc(-n2nc(-c3ccc(Cl)cc3)c3ccccc32)n1.O=COc1csc(-n2nc(-c3ccc(Oc4ccccc4)cc3)c3ccccc32)n1
InChIInChI=1S/C23H15N3O3S.C18H13N3O3S.2C18H13N3O2S.C17H10ClN3O2S/c27-15-28-21-14-30-23(24-21)26-20-9-5-4-8-19(20)22(25-26)16-10-12-18(13-11-16)29-17-6-2-1-3-7-17;1-23-13-8-6-12(7-9-13)17-14-4-2-3-5-15(14)21(20-17)18-19-16(10-25-18)24-11-22;2*1-12-6-8-13(9-7-12)17-14-4-2-3-5-15(14)21(20-17)18-19-16(10-24-18)23-11-22;18-12-7-5-11(6-8-12)16-13-3-1-2-4-14(13)21(20-16)17-19-15(9-24-17)23-10-22/h1-15H;2-11H,1H3;2*2-11H,1H3;1-10H
InChIKeyHHIQBWGWATXDKU-UHFFFAOYSA-N
XLogP21.49
TPSA303.51 Ų
H-Bond Donors
H-Bond Acceptors32
Rotatable Bonds23
Heavy Atoms127
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001791.43
LogP ≤ 521.49
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1032

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'aldehyde', 'substructure': 'N/A'}

Analyze [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate?
The IUPAC name of [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate (CID 158479488) is [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate.
What is the SMILES notation for [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate?
The canonical SMILES for [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate is COc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.Cc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.Cc1ccc(-c2nn(-c3nc(OC=O)cs3)c3ccccc23)cc1.O=COc1csc(-n2nc(-c3ccc(Cl)cc3)c3ccccc32)n1.O=COc1csc(-n2nc(-c3ccc(Oc4ccccc4)cc3)c3ccccc32)n1.
What is the InChIKey of [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate?
The InChIKey is HHIQBWGWATXDKU-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H15N3O3S.C18H13N3O3S.2C18H13N3O2S.C17H10ClN3O2S/c27-15-28-21-14-30-23(24-21)26-20-9-5-4-8-19(20)22(25-26)16-10-12-18(13-11-16)29-17-6-2-1-3-7-17;1-23-13-8-6-12(7-9-13)17-14-4-2-3-5-15(14)21(20-17)18-19-16(10-25-18)24-11-22;2*1-12-6-8-13(9-7-12)17-14-4-2-3-5-15(14)21(20-17)18-19-16(10-24-18)23-11-22;18-12-7-5-11(6-8-12)16-13-3-1-2-4-14(13)21(20-16)17-19-15(9-24-17)23-10-22/h1-15H;2-11H,1H3;2*2-11H,1H3;1-10H.
What are the key properties of [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate?
[2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate has a molecular weight of 1791.43 g/mol, XLogP of 21.49, 23 rotatable bonds, 0 hydrogen bond donors, and 32 hydrogen bond acceptors.
Where does this data come from?
All data for [2-[3-(4-chlorophenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;[2-[3-(4-methoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate;bis([2-[3-(4-methylphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate);[2-[3-(4-phenoxyphenyl)indazol-1-yl]-1,3-thiazol-4-yl] formate is sourced from PubChem (CID 158479488), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).